$54.5MSeed, 10 July 2025
Funds the lead corrector program and discovery of a first-in-class potentiator.
- Amount
- $54.5M
- Stage
- Seed
- Announced
- 10 July 2025
- Lead
- 5AM Ventures
- Other investors
- Atlas Venture, OrbiMed, Qiming Venture Partners USA
- Use of funds
- Funds the lead corrector program and discovery of a first-in-class potentiator.
- Checked
- Announced by the company
- Sources
- Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding - BioPharma Dive businesswire.com
Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding biopharmadive.com
Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding - BioPharma Dive pulse2.com